Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Jan
2
2025
 APHIS Restarts Permitting and “Am I Regulated” Processes for Products of Biotechnology Bergeson & Campbell, P.C.
Jan
2
2025
 What Food Product Companies Need to Know About the New Proposition 65 Warning Requirements ArentFox Schiff LLP
Dec
31
2024
 FDA Issues New Cosmetics Proposed Rule: Let’s Talk About Talc ArentFox Schiff LLP
Dec
31
2024
 FDA Sets Uniform Compliance Date for New Food Labeling Rules Keller and Heckman LLP
Dec
30
2024
 CODEX ALIMENTARIUS: Main Outcome of the 47th session (CAC47) Keller and Heckman LLP
Dec
30
2024
 Key State Laws Set to Take Effect on January 1, 2025 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Dec
30
2024
 High Stakes and Political Blazes: Top 10 Cannabis Trends of 2024 Bradley Arant Boult Cummings LLP
Dec
30
2024
 FDA Sued Over Laboratory Developed Tests Final Rule Robinson & Cole LLP
Dec
27
2024
 FDA Seeks Comments on Updates to MoCRA Guidance on Registration, Listing of Cosmetic Product Facilities McDermott Will & Emery
Dec
26
2024
 CTP Advances Proposal to Set Maximum Nicotine Level in Cigarettes Keller and Heckman LLP
Dec
23
2024
 USDA Issues Streamlined Regulation for Biobased Markets (BioPreferred) Program Bergeson & Campbell, P.C.
Dec
23
2024
 ECHA Publishes Second Interim Evaluation of EUON Bergeson & Campbell, P.C.
Dec
23
2024
 Federal Circuit Decides Case Involving Orange Book Listing of Device Patents Polsinelli PC
Dec
23
2024
 USDA Reverts to Pre-2020 Regulatory Framework for Genetically Engineered Organisms Following California Federal Court Ruling Beveridge & Diamond PC
Dec
23
2024
 Social Consumption Lounges in Massachusetts: Proposed Rules Blank Rome LLP
Dec
20
2024
 The Legal and Economic Realities of Medicare Drug Pricing: Navigating Opportunities and Challenges Sheppard, Mullin, Richter & Hampton LLP
Dec
20
2024
 GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List Foley & Lardner LLP
Dec
20
2024
 FDA To Publish Final Rule Defining “Healthy” Claims Keller and Heckman LLP
Dec
19
2024
 New Accelerated Approval Guidance Underscores Need for Accountability Sheppard, Mullin, Richter & Hampton LLP
Dec
19
2024
 FDA Finalizes "Healthy" Claims Rule Hunton Andrews Kurth
Dec
19
2024
 Ninth Circuit Precedent Limits Fraud-Based Label Claims Foley & Lardner LLP
Dec
19
2024
 First-Ever Corporate Integrity Agreement with Consulting Firm in Opioid Crisis-Related Resolution of Civil and Criminal Investigations Tycko & Zavareei LLP
Dec
19
2024
 The Best of Intentions: State Law Protections for Employee Cannabis Use May Not Protect Them After All Bradley Arant Boult Cummings LLP
Dec
19
2024
 The Grass May Not Be Greener in Texas: New Bill Seeks to Ban Hemp-Derived THC Products ArentFox Schiff LLP
Dec
19
2024
 Florida Employers Should Consider Accommodations for Off-Duty Use of Medical Marijuana, Court Rules Jackson Lewis P.C.
Dec
19
2024
 Factors Courts Commonly Consider When Deciding Motions to Transfer in ANDA Litigation Womble Bond Dickinson (US) LLP
Dec
19
2024
 The Devil Is in the Details: Bioequivalence, In Vitro Testing Not Enough to Establish Infringement McDermott Will & Emery
Dec
19
2024
 FDA Shares Testing Results for PFAS in Clams Keller and Heckman LLP
Displaying 1 - 28 of 11837
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins